Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about INSULIN: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
No summary available yet. View on Wiki →
| Name | INSULIN |
| Summary | Phase 2 trial combining intranasal insulin with empagliflozin (SGLT2 inhibitor) for AD, targeting brain insulin resistance and cerebral glucose metabolism. |
| Key Genes/Proteins | AMYLOID, AMPK, MTOR, TNF, BDNF, IL-6 |
| Related Diseases | ALZHEIMER'S DISEASE, PARKINSON'S DISEASE, NEURODEGENERATION |
| Related Pathways | PI3K |
| Linked Hypotheses | 3 hypotheses |
Knowledge base pages for this entity
graph TD
INSULIN["INSULIN"]
INSULIN -->|"activates"| TUG["TUG"]
INSULIN -->|"regulates"| blood_glucose_levels["blood glucose levels"]
INSULIN -->|"regulates"| glucose_metabolism["glucose metabolism"]
INSULIN -->|"activates"| neuron_outgrowth["neuron outgrowth"]
INSULIN -->|"activates"| Insulin_receptor["Insulin receptor"]
MTOR["MTOR"] -->|"activates"| INSULIN
APOPTOSIS["APOPTOSIS"] -->|"inhibits"| INSULIN
AKT["AKT"] -->|"activates"| INSULIN
AUTOPHAGY["AUTOPHAGY"] -->|"activates"| INSULIN
EGFR["EGFR"] -->|"activates"| INSULIN
SQSTM1["SQSTM1"] -->|"activates"| INSULIN
PI3K["PI3K"] -->|"mediates"| INSULIN
NEUROINFLAMMATION["NEUROINFLAMMATION"] -->|"regulates"| INSULIN| Target | Relation | Type | Str |
|---|---|---|---|
| TUG | activates | entity | 0.95 |
| Food Intake | regulates | process | 0.90 |
| PI3K | activates | pathway | 0.85 |
| IDE | upregulates | protein | 0.80 |
| NEURODEGENERATION | regulates | disease | 0.80 |
| NEURODEGENERATION | treats | disease | 0.80 |
| Proteins | activates | protein | 0.50 |
| RAPAMYCIN | activates | concept | 0.50 |
| PEROXISOME | activates | concept | 0.50 |
| FIBROBLASTS | activates | concept | 0.50 |
| CIRCADIAN CLOCK GENES | activates | concept | 0.50 |
| METFORMIN | associated_with | concept | 0.50 |
| GLUCOSE METABOLISM | activates | concept | 0.50 |
| Proteins | associated_with | protein | 0.50 |
| NUCLEUS | interacts_with | concept | 0.50 |
| IGF-1 | activates | concept | 0.50 |
| CYTOKINE | activates | concept | 0.50 |
| METFORMIN | activates | concept | 0.50 |
| Neuroprotection | protects_against | process | 0.50 |
| PI3K/AKT/mTOR | activates | pathway | 0.50 |
| PI3K/AKT/mTOR | inhibits | pathway | 0.50 |
| MTOR SIGNALING | inhibits | concept | 0.50 |
| GLUCOSE METABOLISM | inhibits | concept | 0.50 |
| CELL PROLIFERATION | associated_with | concept | 0.50 |
| RAPAMYCIN | associated_with | concept | 0.50 |
| METFORMIN | inhibits | concept | 0.50 |
| CENTRAL NERVOUS SYSTEM | associated_with | concept | 0.50 |
| Proteins | interacts_with | protein | 0.50 |
| ENDOPLASMIC RETICULUM STRESS | associated_with | concept | 0.50 |
| ENDOPLASMIC RETICULUM | associated_with | concept | 0.50 |
| CHRONIC INFLAMMATION | activates | concept | 0.50 |
| IGF-1 | regulates | concept | 0.50 |
| RAPAMYCIN | regulates | concept | 0.50 |
| B CELLS | activates | concept | 0.50 |
| Gut Microbiota | inhibits | process | 0.50 |
| CHRONIC INFLAMMATION | associated_with | concept | 0.50 |
| Cognitive Decline | activates | disease | 0.50 |
| Gut Microbiota | regulates | process | 0.50 |
| CHRONIC INFLAMMATION | interacts_with | concept | 0.50 |
| Gut Microbiota | activates | process | 0.50 |
| Gut Microbiota | interacts_with | process | 0.50 |
| SEROTONIN | inhibits | concept | 0.50 |
| SEROTONIN | activates | concept | 0.50 |
| CHRONIC INFLAMMATION | inhibits | concept | 0.50 |
| ENDOTHELIAL CELLS | activates | concept | 0.50 |
| ENDOTHELIAL CELLS | associated_with | concept | 0.50 |
| RAPAMYCIN | inhibits | concept | 0.50 |
| Source | Relation | Type | Str |
|---|---|---|---|
| ALZHEIMER'S DISEASE | associated_with | disease | 1.00 |
| PARKINSON'S DISEASE | associated_with | disease | 1.00 |
| AMYLOID | associated_with | protein | 1.00 |
| AMPK | associated_with | gene | 0.90 |
| MTOR | activates | gene | 0.82 |
| TNF | associated_with | gene | 0.82 |
| BDNF | associated_with | gene | 0.82 |
| IL-6 | associated_with | gene | 0.82 |
| NF-KB | associated_with | protein | 0.82 |
| MTOR | associated_with | gene | 0.82 |
| AKT | activates | gene | 0.74 |
| AMPK | activates | gene | 0.74 |
| TAU | associated_with | protein | 0.72 |
| AMYLOID | inhibits | protein | 0.66 |
| AKT | associated_with | gene | 0.66 |
| PI3K | inhibits | gene | 0.66 |
| SOD1 | associated_with | gene | 0.66 |
| APOE | associated_with | gene | 0.66 |
| JUN | associated_with | gene | 0.56 |
| TAU | phosphorylates | protein | 0.56 |
| AKT | inhibits | gene | 0.56 |
| TAU | activates | protein | 0.56 |
| ASTROCYTES | inhibits | cell_type | 0.56 |
| GLUT4 | activates | concept | 0.50 |
| OBESITY | activates | disease | 0.50 |
| ACTB | activates | gene | 0.50 |
| Autophagy | activates | process | 0.50 |
| PPARGC1A | activates | gene | 0.50 |
| RPS6 | activates | gene | 0.50 |
| CTSD | activates | gene | 0.50 |
| mTOR | activates | entity | 0.50 |
| PPARG | activates | gene | 0.50 |
| MAP1LC3B | activates | gene | 0.50 |
| RPS6KB1 | activates | gene | 0.50 |
| PPARA | activates | gene | 0.50 |
| PIK3C3 | activates | gene | 0.50 |
| RUBCN | activates | gene | 0.50 |
| LRP2 | activates | gene | 0.50 |
| SREBF1 | activates | gene | 0.50 |
| EIF4EBP1 | activates | gene | 0.50 |
| RIBOSOMAL PROTEIN S6 | activates | protein | 0.50 |
| RUBICON | activates | protein | 0.50 |
| LAMP1 | activates | protein | 0.50 |
| RAB7A | activates | protein | 0.50 |
| ISCHEMIA | activates | disease | 0.50 |
| MTORC1 | activates | concept | 0.50 |
| Epithelial Cell | activates | cell_type | 0.50 |
| NADH | activates | concept | 0.50 |
| DAG1 | activates | gene | 0.50 |
| IGF1R | activates | gene | 0.50 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| Brain Insulin Resistance with Glucose Transporter Dysfunctio | 0.398 | neurodegeneration | Metabolic reprogramming in neurodegenera |
Scientific analyses that reference this entity
neurodegeneration | 2026-04-02 | 3 hypotheses Top: 0.398
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| Comparative study of the glucolipid profile and GLUTs gene expression in respons [PMID:41232212] | ["Wang Z", "Wang H", "Du P", "Zhang X", | Poultry science | 2025 | 0 |
| Altered Glut4, IRAP, and Brain Insulin Signaling in a Mouse Model of Epilepsy an [PMID:41369048] | ["Xu W", "Neal E", "Barlow N", "Thompson | Journal of neurochemistry | 2025 | 0 |
| Targeting glucose transporters in parkinson's disease: a novel metabolic approac [PMID:40879857] | ["Singh G", "Ansari S", "Aran K"] | Metabolic brain disease | 2025 | 0 |
| Tirzepatide prevents neurodegeneration through multiple molecular pathways. [PMID:38287296] | Fontanella RA, Ghosh P, Pesapane A, Takt | Journal of translational medic | 2024 | 0 |
| A high fat diet potentiates neonatal iron overload-induced memory impairments in [PMID:38358514] | ["do Nascimento F", "de Freitas B", "Dos | European journal of nutrition | 2024 | 0 |
| [WALANT - Wide Awake Local Anaesthesia No Tourniquet: Complications in elective [PMID:35168268] | Wieschollek S, Forster S, Megerle K | Handchirurgie, Mikrochirurgie, | 2022 | 0 |
| Complete Genome Sequence of Geobacter sp. Strain FeAm09, a Moderately Acidophili [PMID:33446582] | Yadav P, Antony-Babu S, Hayes E, Healy O | Microbiology resource announce | 2021 | 0 |
| Engineering complex communities by directed evolution. [PMID:33986540] | Chang CY, Vila JCC, Bender M, Li R, Mank | Nature ecology & evolution | 2021 | 0 |
| Successful Nonoperative Treatment of Osteochondritis Dissecans of the Humeral Ca [PMID:34825100] | Tajika T, Kuboi T, Endo F, Hatori Y, Sai | Progress in rehabilitation med | 2021 | 0 |